Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

IL-23 in colitis: targeting the progenitors.

Tang C, Iwakura Y.

Immunity. 2012 Dec 14;37(6):957-9. doi: 10.1016/j.immuni.2012.11.010.

2.

Interleukin-19 protects mice from innate-mediated colonic inflammation.

Azuma YT, Matsuo Y, Kuwamura M, Yancopoulos GD, Valenzuela DM, Murphy AJ, Nakajima H, Karow M, Takeuchi T.

Inflamm Bowel Dis. 2010 Jun;16(6):1017-28. doi: 10.1002/ibd.21151.

PMID:
19834971
4.

Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.

Atreya R, Neurath MF.

Clin Rev Allergy Immunol. 2005 Jun;28(3):187-96. Review.

PMID:
16129903
5.

Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.

Nakase H, Okazaki K, Tabata Y, Chiba T.

J Gastroenterol. 2003 Mar;38 Suppl 15:59-62. Review.

PMID:
12698874
6.
7.

Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease.

Khalil PN, Weiler V, Nelson PJ, Khalil MN, Moosmann S, Mutschler WE, Siebeck M, Huss R.

Gastroenterology. 2007 Mar;132(3):944-54. Epub 2006 Dec 19.

PMID:
17383423
8.

Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.

Yang X, Meng S, Jiang H, Chen T, Wu W.

Scand J Gastroenterol. 2010 Oct;45(10):1168-77. doi: 10.3109/00365521.2010.490596.

PMID:
20469967
9.

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.

Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick D.

J Clin Invest. 2006 May;116(5):1310-6.

10.
11.

Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells.

Sasaoka T, Ito M, Yamashita J, Nakajima K, Tanaka I, Narita M, Hara Y, Hada K, Takahashi M, Ohno Y, Matsuo T, Kaneshiro Y, Tanaka H, Kaneko K.

Am J Physiol Gastrointest Liver Physiol. 2011 Apr;300(4):G568-76. doi: 10.1152/ajpgi.00329.2010. Epub 2010 Dec 30.

12.

Cytokines in inflammatory bowel disease.

Kmieć Z.

Arch Immunol Ther Exp (Warsz). 1998;46(3):143-55. Review.

PMID:
9704146
13.

Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.

Reddy KP, Markowitz JE, Ruchelli ED, Baldassano RN, Brown KA.

Dig Dis Sci. 2007 Feb;52(2):365-72. Epub 2007 Jan 12.

PMID:
17219072
14.

Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease.

Zhong W, Kolls JK, Chen H, McAllister F, Oliver PD, Zhang Z.

Front Biosci. 2008 Jan 1;13:1654-64. Review.

PMID:
17981657
15.

Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease.

Kim YS, Son M, Ko JI, Cho H, Yoo M, Kim WB, Song IS, Kim CY.

Arch Pharm Res. 1999 Aug;22(4):354-60.

PMID:
10489873
16.

Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease.

Hundorfean G, Neurath MF, Mudter J.

Inflamm Bowel Dis. 2012 Jan;18(1):180-6. doi: 10.1002/ibd.21677. Epub 2011 Mar 4. Review.

PMID:
21381156
17.

Probiotics and inflammatory bowel disease.

Kwon J, Farrell R.

BioDrugs. 2003;17(3):179-86. Review.

PMID:
12749754
18.

Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis.

Lee M, Kovacs-Nolan J, Yang C, Archbold T, Fan MZ, Mine Y.

J Agric Food Chem. 2009 Mar 25;57(6):2233-40. doi: 10.1021/jf803133b.

PMID:
19231858
19.

CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.

Singh UP, Venkataraman C, Singh R, Lillard JW Jr.

Endocr Metab Immune Disord Drug Targets. 2007 Jun;7(2):111-23. Review.

PMID:
17584151
20.

Supplemental Content

Support Center